Chronic kidney disease (CKD) is a potent risk factor for coronary artery disease and premature death. However, the optimal strategies for revascularization versus medical management remain unclear. Charytan et al. address this knowledge gap with a well-structured individual patient meta-analysis. We discuss the implications of their findings for patients with moderate CKD and highlight the need for randomized, controlled trials on this issue in more severe CKD.
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.